tiprankstipranks
Trending News
More News >
Evoke Pharma (EVOK)
NASDAQ:EVOK
US Market

Evoke Pharma (EVOK) Income Statement

Compare
501 Followers

Evoke Pharma Income Statement

Last quarter (Q3 2025), Evoke Pharma's total revenue was $4.28M, an increase of 61.40% from the same quarter last year. In Q3, Evoke Pharma's net income was $-1.16M. See Evoke Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.25M$ 5.18M$ 2.51M$ 1.62M$ 23.02K
Gross Profit
$ 9.89M$ 4.98M$ 2.14M$ 1.29M$ -63.69K
Operating Expenses
$ 15.10M$ 12.41M$ 9.92M$ 9.44M$ 12.98M
Depreciation and Amortization
$ 5.20M$ 138.60K$ 0.00$ 0.00$ 0.00
EBITDA
$ 353.31K$ -7.15M$ -7.72M$ -8.04M$ -13.04M
Operating Income
$ -5.20M$ -7.43M$ -7.79M$ -8.15M$ -13.05M
Other Income/Expenses
$ -148.06K$ -361.40K$ -437.99K$ -386.31K$ -107.32K
Pretax Income
$ -5.35M$ -7.79M$ -8.22M$ -8.54M$ -13.15M
Net Income
$ -5.35M$ -7.79M$ -8.22M$ -8.54M$ -13.15M
Per Share Metrics
Basic EPS
$ -2.81$ -27.97$ -31.16$ -40.40$ -74.91
Diluted EPS
$ -2.81$ -27.97$ -31.16$ -40.40$ -74.91
Weighted Average Shares Outstanding
1.91M 278.56K 261.97K 223.51K 177.03K
Weighted Average Shares Outstanding (Diluted)
1.91M 278.56K 261.97K 223.51K 177.03K
Currency in USD

Evoke Pharma Earnings and Revenue History